Survival following treatment of a cardiac malignant fibrous histiocytoma

Stefano Schena, Alessandro Caniglia, Alfonso Agnino, Gilda Caruso, Giovanni Ferlan

Research output: Contribution to journalArticle

Abstract

The authors report the successful surgical and chemotherapeutic management of a malignant fibrous histiocytoma with localization in the heart. This rare malignancy has specific morphologic characteristics and is diagnosed in adults when it is already locally aggressive or metastasized. The average survival time for patients with malignant fibrous histiocytoma is < 12 months. Neither clinical nor instrumental signs of recurrence have been detected in this patient after an aggressive surgical resection and a specific therapeutic approach.

Original languageEnglish (US)
Article number39040
Pages (from-to)271-273
Number of pages3
JournalCHEST
Volume118
Issue number1
DOIs
StatePublished - Jul 2000
Externally publishedYes

Keywords

  • Chemotherapy
  • Heart
  • Long-term survival
  • Malignant fibrous histiocytoma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Survival following treatment of a cardiac malignant fibrous histiocytoma'. Together they form a unique fingerprint.

  • Cite this

    Schena, S., Caniglia, A., Agnino, A., Caruso, G., & Ferlan, G. (2000). Survival following treatment of a cardiac malignant fibrous histiocytoma. CHEST, 118(1), 271-273. [39040]. https://doi.org/10.1378/chest.118.1.271